TARDBP and amyotrophic lateral sclerosis: It has been shown that loss-of-function mutations in dynactin 1 (DCTN1) can lead to the development of ALS pathology, mislocalization and aggregation of TDP-43, and obvious upper motor neuron symptoms with a typical progression (Deshimaru et al., 2021; He et al., 2022).